Ciprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes

Simple item page
dc.contributor.authorBaltas Ioannis
dc.contributor.authorHederih Jure
dc.contributor.authorKvam Nora
dc.contributor.authorKavallieros Konstantinos
dc.contributor.authorKonstantinou Giannis
dc.contributor.authorKoutoumanou Eirini
dc.contributor.authorGibani Malick M.
dc.contributor.authorGilchrist Mark
dc.contributor.authorGrandjean Louis
dc.contributor.authorDavies Frances
dc.contributor.authorStringaris Kate
dc.contributor.authorGant Vanya
dc.contributor.authorJiří Pavlů
dc.date.accessioned2026-05-05T08:38:35Z
dc.date.issued2026-6
dc.identifier.doi10.1016/j.ijid.2026.108660
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/12526
dc.identifier.uri.pubmedhttps://doi.org/10.1016/j.ijid.2026.108660
dc.sourceInternational Journal of Infectious Diseases
dc.titleCiprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes

Files

Collections

Published